Amsterdam 2013 Programme Satellite Meetings Registration Exhibition Virtual Exhibition Hotels Visa Letter Invitation
Search Abstracts by author or title
(results will display both Free Papers & Poster)

Comparison of visual outcomes following cataract surgery between two multifocal intraocular lenses: SeeLens MF and AcrySof SN6AD1

Poster Details

First Author: G.Vizzari ITALY

Co Author(s):    N. Maccari   P. Bordin           

Abstract Details



Purpose:

To compare the postoperative visual outcomes after cataract surgery in patients implanted with Seelens MF multifocal intraocular lens (IOL) versus patients with Acrisoft SN6AD1 multifocal IOL.

Setting:

Eye Clinic, Department of Neurological and Visual Sciences, Hospital of Legnago, Verona, Italy.

Methods:

Fiftytwo eyes (26 eyes from 13 patients implanted with Seelens MF (Hanita Lenses, Hanita, Israel) and 26 eyes from 13 patients with Acrisoft SN6AD1 (Alcon Laboratories, Fort Worth, Texas, USA)) were evaluated in a cross-sectional study. Each patient underwent standardized phacoemulsification with in-the-bag implantation of the IOL. Uncorrected distance visual acuity (UCDVA) were measured using a Snellen table. Uncorrected intermediate visual acuity (UCIVA) was assessed at 80 cm with a Snellen chart. Uncorrected near visual acuity (UCNVA) was obtained at 40 cm using a Jaeger chart.

Results:

After a mean follow-up period of 95 ? 22.4 days, the mean UCDVA of the Seelens MF improved significantly after surgery changing from 0.52 ? 0.14 to 0.92 ? 0.07 (30% of the eyes achieved 1.0) (p<0.001), the mean UCIVA was of 0.93 ? 0.19 and the mean UCNVA was 2.10 ? 0.65 J, with 26,9% of the eyes attaining J1, and 38% J2. While for the Acrisoft SN6AD1 we observed a changing of the mean UCDVA from 0.46 ? 0.06 to 0.89 ? 0.09 (28% of the eyes achieved 1.0) (p<0.001), a mean UCIVA of 1.01 ? 0.12, with 46.2% of the eyes achieving 1.25 and a mean UCNVA of 2.38 ? 0.91 J, with 19.2% of the eyes attaining J1 and 34.6% J2.

Conclusions:

UCDVA improved significantly after surgery in all patients. The Seelens MF provided a little bit better near visual outcomes than Acrisoft SN6AD1, with 84.6% of the eyes achieving J3 or better without spectacle correction. The subjective perception of glare was less for Seelens MF than Acrisoft SN6AD1.

Financial Disclosure:

NONE

Back to previous